Literature DB >> 3305965

Model experiments on anticalcinotic and antiarteriosclerotic arterial protection with calcium antagonists.

A Fleckenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3305965     DOI： 10.1016/s0022-2828(87)80008-1

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  4 in total

1.  Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).

Authors:  P R Lichtlen; P G Hugenholtz; W Rafflenbeul; H Hecker; S Jost; P Nikutta; J W Deckers
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Excessive mural calcium overload--a predominant causal factor in the development of stenosing coronary plaques in humans.

Authors:  A Fleckenstein; M Frey; F Thimm; G Fleckenstein-Grün
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).

Authors:  R H Grimm; J M Flack; R Byington; G Bond; S Brugger
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 4.  Discovery and Development of Calcium Channel Blockers.

Authors:  Théophile Godfraind
Journal:  Front Pharmacol       Date:  2017-05-29       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.